(1)
“To Study The Association Of Leptin As A Predictive Marker In Obese And Non-Obese Women With Polycystic Ovary Syndrome Patients. ” Journal of Pharmaceutical Negative Results 2022, 3930-3940. https://doi.org/10.47750/pnr.2022.13.S08.495.